Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores
- 1 August 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 188 (2) , 279-285
- https://doi.org/10.1016/j.expneurol.2004.02.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Development of the Nitrone‐Based Spin Trap Agent NXY‐059 to Treat Acute Ischemic StrokeCNS Drug Reviews, 2003
- Ebselen, a Seleno-Organic Antioxidant, Is Neuroprotective After Embolic Strokes in RabbitsStroke, 2003
- Development of thrombolytic therapy for stroke: a perspectiveExpert Opinion on Investigational Drugs, 2002
- Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspectiveClinical and Experimental Pharmacology and Physiology, 2002
- Reducing Bleeding Complications After Thrombolytic Therapy for StrokeCNS Drugs, 2001
- Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 2000
- Pathobiology of ischaemic stroke: an integrated viewPublished by Elsevier ,1999
- Neuroprotective Effects of a Novel Nitrone, NXY-059, after Transient Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1999
- Diagnosis and treatment of ischemic strokeThe American Journal of Medicine, 1999
- Hyperacute Stroke Therapy With Tissue Plasminogen ActivatorThe American Journal of Cardiology, 1997